HealthEquity Statistics
Total Valuation
HealthEquity has a market cap or net worth of $6.82 billion. The enterprise value is $7.35 billion.
| Market Cap | 6.82B |
| Enterprise Value | 7.35B |
Important Dates
The next estimated earnings date is Monday, June 3, 2024, after market close.
| Earnings Date | Jun 3, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
HealthEquity has 86.16 million shares outstanding. The number of shares has increased by 2.98% in one year.
| Shares Outstanding | 86.16M |
| Shares Change (YoY) | +2.98% |
| Shares Change (QoQ) | +0.67% |
| Owned by Insiders (%) | 2.22% |
| Owned by Institutions (%) | 102.13% |
| Float | 84.49M |
Valuation Ratios
The trailing PE ratio is 123.75 and the forward PE ratio is 29.57. HealthEquity's PEG ratio is 2.29.
| PE Ratio | 123.75 |
| Forward PE | 29.57 |
| PS Ratio | 6.83 |
| Forward PS | 6.11 |
| PB Ratio | 3.35 |
| P/FCF Ratio | 34.12 |
| PEG Ratio | 2.29 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.93, with an EV/FCF ratio of 36.76.
| EV / Earnings | 131.98 |
| EV / Sales | 7.36 |
| EV / EBITDA | 25.93 |
| EV / EBIT | 56.35 |
| EV / FCF | 36.76 |
Financial Position
The company has a current ratio of 4.76, with a Debt / Equity ratio of 0.46.
| Current Ratio | 4.76 |
| Quick Ratio | 4.35 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | 3.29 |
| Debt / FCF | 4.67 |
| Interest Coverage | 2.35 |
Financial Efficiency
Return on equity (ROE) is 2.80% and return on invested capital (ROIC) is 2.94%.
| Return on Equity (ROE) | 2.80% |
| Return on Assets (ROA) | 1.80% |
| Return on Capital (ROIC) | 2.94% |
| Revenue Per Employee | $317,329 |
| Profits Per Employee | $17,686 |
| Employee Count | 3,150 |
| Asset Turnover | 0.32 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HealthEquity has paid $19.33 million in taxes.
| Income Tax | 19.33M |
| Effective Tax Rate | 25.76% |
Stock Price Statistics
The stock price has increased by +40.70% in the last 52 weeks. The beta is 0.55, so HealthEquity's price volatility has been lower than the market average.
| Beta (1Y) | 0.55 |
| 52-Week Price Change | +40.70% |
| 50-Day Moving Average | 81.02 |
| 200-Day Moving Average | 72.52 |
| Relative Strength Index (RSI) | 44.90 |
| Average Volume (30 Days) | 555,040 |
Short Selling Information
The latest short interest is 2.98 million, so 3.46% of the outstanding shares have been sold short.
| Short Interest | 2.98M |
| Short Previous Month | 3.04M |
| Short % of Shares Out | 3.46% |
| Short % of Float | 3.53% |
| Short Ratio (days to cover) | 5.20 |
Income Statement
In the last 12 months, HealthEquity had revenue of $999.59 million and earned $55.71 million in profits. Earnings per share was $0.64.
| Revenue | 999.59M |
| Gross Profit | 622.64M |
| Operating Income | 117.70M |
| Pretax Income | 75.04M |
| Net Income | 55.71M |
| EBITDA | 283.57M |
| EBIT | 130.50M |
| Earnings Per Share (EPS) | $0.64 |
Balance Sheet
The company has $403.98 million in cash and $933.14 million in debt, giving a net cash position of -$529.16 million or -$6.14 per share.
| Cash & Cash Equivalents | 403.98M |
| Total Debt | 933.14M |
| Net Cash | -529.16M |
| Net Cash Per Share | -$6.14 |
| Equity / Book Value | 2.04B |
| Book Value Per Share | 23.62 |
| Working Capital | 440.35M |
Cash Flow
In the last 12 months, operating cash flow was $242.83 million and capital expenditures -$42.82 million, giving a free cash flow of $200.01 million.
| Operating Cash Flow | 242.83M |
| Capital Expenditures | -42.82M |
| Free Cash Flow | 200.01M |
| FCF Per Share | $2.34 |
Margins
Gross margin is 62.29%, with operating and profit margins of 11.77% and 5.57%.
| Gross Margin | 62.29% |
| Operating Margin | 11.77% |
| Pretax Margin | 7.51% |
| Profit Margin | 5.57% |
| EBITDA Margin | 28.37% |
| EBIT Margin | 13.05% |
| FCF Margin | 20.01% |
Dividends & Yields
HealthEquity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.98% |
| Shareholder Yield | -2.98% |
| Earnings Yield | 0.82% |
| FCF Yield | 2.93% |
Analyst Forecast
The average price target for HealthEquity is $95.45, which is 20.52% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $95.45 |
| Price Target Difference | 20.52% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HealthEquity has an Altman Z-Score of 4.34 and a Piotroski F-Score of 8.
| Altman Z-Score | 4.34 |
| Piotroski F-Score | 8 |